ISN Journal summaries on pegcetacoplan, AVF maturation failure, and primary hyperoxaluria type 1
Kidney International® Real-world outcomes of pegcetacoplan in primary membranoproliferative glomerulonephritis Pegcetacoplan is being explored as a treatment for C3 glomerulopathy and primary immune-complex membranoproliferative glomerulonephritis, but real-world evidence remains limited. This observational study followed 25 pediatric and adult patients treated outside clinical trials, most of whom had not responded to conventional therapies. Pegcetacoplan was associated with rapid...